Cargando…

In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?

IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The clinical course and the response to therapy are usually assessed with proteinur...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimarchi, H., Paulero, M., Canzonieri, R., Schiel, A., Iotti, A., Costales-Collaguazo, C., Stern, A., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Rengel, T., Gonzalez-Hoyos, I., Muryan, A., Zotta, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394405/
https://www.ncbi.nlm.nih.gov/pubmed/28473934
http://dx.doi.org/10.1155/2017/1292531
_version_ 1783229726404378624
author Trimarchi, H.
Paulero, M.
Canzonieri, R.
Schiel, A.
Iotti, A.
Costales-Collaguazo, C.
Stern, A.
Forrester, M.
Lombi, F.
Pomeranz, V.
Iriarte, R.
Rengel, T.
Gonzalez-Hoyos, I.
Muryan, A.
Zotta, E.
author_facet Trimarchi, H.
Paulero, M.
Canzonieri, R.
Schiel, A.
Iotti, A.
Costales-Collaguazo, C.
Stern, A.
Forrester, M.
Lombi, F.
Pomeranz, V.
Iriarte, R.
Rengel, T.
Gonzalez-Hoyos, I.
Muryan, A.
Zotta, E.
author_sort Trimarchi, H.
collection PubMed
description IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The clinical course and the response to therapy are usually assessed with proteinuria and serum creatinine. Validated biomarkers have not been identified yet. In this report, we present a case of acute renal injury with proteinuria and microscopic hematuria in a young male. A kidney biopsy disclosed IgA nephropathy. Podocyturia was significantly elevated compared to normal subjects. Proteinuria, renal function, and podocyturia improved promptly after steroids and these variables remained normal after one year of follow-up, when steroids had already been discontinued and patient continued on valsartan and amiloride. Our report demonstrates that podocyturia is critically elevated during an acute episode of IgA nephropathy, and its occurrence may explain the grim long-term prognosis of this entity. Whether podocyturia could be employed in IgA nephropathy as a trustable biomarker for treatment assessment or even for early diagnosis of IgA nephropathy relapses should be further investigated.
format Online
Article
Text
id pubmed-5394405
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-53944052017-05-04 In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride? Trimarchi, H. Paulero, M. Canzonieri, R. Schiel, A. Iotti, A. Costales-Collaguazo, C. Stern, A. Forrester, M. Lombi, F. Pomeranz, V. Iriarte, R. Rengel, T. Gonzalez-Hoyos, I. Muryan, A. Zotta, E. Case Rep Nephrol Case Report IgA nephropathy is the most frequent cause of primary glomerulonephritis, portends erratic patterns of clinical presentation, and lacks specific treatment. In general, it slowly progresses to end-stage renal disease. The clinical course and the response to therapy are usually assessed with proteinuria and serum creatinine. Validated biomarkers have not been identified yet. In this report, we present a case of acute renal injury with proteinuria and microscopic hematuria in a young male. A kidney biopsy disclosed IgA nephropathy. Podocyturia was significantly elevated compared to normal subjects. Proteinuria, renal function, and podocyturia improved promptly after steroids and these variables remained normal after one year of follow-up, when steroids had already been discontinued and patient continued on valsartan and amiloride. Our report demonstrates that podocyturia is critically elevated during an acute episode of IgA nephropathy, and its occurrence may explain the grim long-term prognosis of this entity. Whether podocyturia could be employed in IgA nephropathy as a trustable biomarker for treatment assessment or even for early diagnosis of IgA nephropathy relapses should be further investigated. Hindawi 2017 2017-04-03 /pmc/articles/PMC5394405/ /pubmed/28473934 http://dx.doi.org/10.1155/2017/1292531 Text en Copyright © 2017 H. Trimarchi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Trimarchi, H.
Paulero, M.
Canzonieri, R.
Schiel, A.
Iotti, A.
Costales-Collaguazo, C.
Stern, A.
Forrester, M.
Lombi, F.
Pomeranz, V.
Iriarte, R.
Rengel, T.
Gonzalez-Hoyos, I.
Muryan, A.
Zotta, E.
In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
title In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
title_full In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
title_fullStr In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
title_full_unstemmed In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
title_short In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
title_sort in acute iga nephropathy, proteinuria and creatinine are in the spot, but podocyturia operates in silence: any place for amiloride?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394405/
https://www.ncbi.nlm.nih.gov/pubmed/28473934
http://dx.doi.org/10.1155/2017/1292531
work_keys_str_mv AT trimarchih inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT paulerom inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT canzonierir inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT schiela inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT iottia inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT costalescollaguazoc inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT sterna inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT forresterm inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT lombif inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT pomeranzv inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT iriarter inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT rengelt inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT gonzalezhoyosi inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT muryana inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride
AT zottae inacuteiganephropathyproteinuriaandcreatinineareinthespotbutpodocyturiaoperatesinsilenceanyplaceforamiloride